Sort
46,585 grants matching “heart failure”
A Clinical Trial of Aspirin and Simvastatin in Pulmonary Arterial Hypertension
$618,947Steven M Kawut · University Of Pennsylvania · R01 · FY2009 · HL
Early-Stage Chronic Kidney Disease in HIV-infected Individuals
$618,943Gregory M Lucas · Johns Hopkins University · R01 · FY2016 · DA
Native-Controlling Hypertension And Risk through Technology (Native-CHART)
$618,864Denise A Dillard · Washington State University · U54 · FY2021 · MD
Efficacy of Potassium Nitrate in Heart Failure with Preserved Ejection Fraction
$618,771Julio Alonso Chirinos Medina · University Of Pennsylvania · R01 · FY2016 · HL
Label-free single-cell imaging for quality control of cardiomyocyte biomanufacturing
$618,687Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2024 · HL
Efficacy of Potassium Nitrate in Heart Failure with Preserved Ejection Fraction
$618,654Julio Alonso Chirinos Medina · University Of Pennsylvania · R01 · FY2017 · HL
Predictors of CVD among breast cancer survivors in an integrated health system
$618,653Marilyn L Kwan · Kaiser Foundation Research Institute · R01 · FY2020 · CA
KLF14 and Cardiovascular Disease
$618,571Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
KLF14 and Cardiovascular Disease
$618,571Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2021 · HL
KLF14 and Cardiovascular Disease
$618,571Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Novel mechanisms of obliterative pulmonary vascular remodeling and severe pulmonary arterial hypertension
$618,533You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · HL
Targeted fluorescent indicators for endothelial physiology: Ca(II), ROS, NO
$618,469Marcel P Bruchez · Carnegie-Mellon University · R01 · FY2015 · EB
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
$618,448Bernice E. Morrow · Albert Einstein College Of Medicine · R01 · FY2022 · HL
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
$618,448Bernice E. Morrow · Albert Einstein College Of Medicine · R01 · FY2023 · HL
Mechanism of Calcium Regulation in Striated Muscle
$618,302Terence Tao · Boston Biomedical Research Institute · R01 · FY2006 · AR
Cancer Patient Safety Learning Laboratory (CaPSLL): Preventing Clinical Deterioration in Outpatients
$618,254Matthew B Weinger · Vanderbilt University Medical Center · R18 · FY2018 · HS
Cell Biology of Vasopressin-induced Water Channels
$618,232Dennis Brown · Massachusetts General Hospital · R01 · FY2025 · DK
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
$618,148Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · UH3 · FY2023 · HL
Channelopathies of Inflammation
$618,126Ademuyiwa Aromolaran · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL
Stem Cell Therapy, Inflammation and Treatement Response in Alcholoism-Depression Comobidity
$618,005Ihsan M Salloum · University Of Texas Rio Grande Valley · R01 · FY2020 · AA
Long Term Extracorporeal Oxygenating Device
$617,994Jean Montoya · Medarray, Inc. · R44 · FY2007 · HL
Improving Lung Transplant Outcomes with Coping Skills and Physical Activity
$617,934James A. Blumenthal · Duke University · R01 · FY2021 · NR
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
$617,878Jonathan Satin · University Of Kentucky · R01 · FY2024 · HL
Myocardial Steatosis in Women with Coronary Microvascular Dysfunction: Defining the Pathway to Heart Failure with Preserved Ejection Fraction (HFpEF)
$617,876Janet Wei · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity
$617,870Iris Z Jaffe · Tufts Medical Center · R01 · FY2022 · CA